Medscape Conference Coverage, based on selected sessions at the:

International Stroke Conference 2009

February 18 - 20, 2009; San Diego, California

This activity is not sanctioned by, nor a part of, the International Stroke Conference. Conference news does not receive grant support and is produced independently.

Conference News

  • Rupture Risk Higher in Familial vs Sporadic Aneurysms

    Small unruptured aneurysms in those with a family history of aneurysm have a higher risk of rupture than similar-sized sporadic aneurysms, something that should be considered in the management of these patients, researchers say.
    Medscape Medical News, March 13, 2009
  • Silent Cerebral Infarcts Far Outnumber Symptomatic Strokes in Midlife

    New findings from the Framingham Heart Study show that in middle age silent cerebral infarcts are 5 times more common than symptomatic stroke and represent a major, unmeasured portion of the burden of cerebrovascular disease in this population.
    Medscape Medical News, March 5, 2009
  • Combination of Ultrasound, Microspheres, and tPA Shows Promise in Stroke

    Combining transcranial Doppler ultrasound with microspheres and tissue plasminogen activator is more effective than tPA alone in treating ischemic stroke.
    Medscape Medical News, February 27, 2009
  • Primary Stenting in Ischemic Stroke Promising; Pilot Extension Pl

    Pilot results using primary stenting in a series of 20 patients with acute ischemic stroke has shown that recanalization of the infarct vessel was achieved in all patients, with 45% achieving a modified Rankin Scale score of 0 or 1.
    Medscape Medical News, February 26, 2009
  • Laser Stroke Treatment Fails Primary End Point, but Phase 3 Trial

    Although the NEST-2 study of laser therapy in ischemic stroke failed its primary end point, investigators plan to go ahead with a phase 3 trial of the therapy, this time excluding severe stroke patients, whom subgroup analysis suggested did not benefit.
    Medscape Medical News, February 25, 2009
  • Women with Stroke, TIA, More Likely Than Men to Report Mental Status Change

    Women who suffer a stroke or transient ischemic attack are more likely than men to report nontraditional symptoms, particularly altered mental status, new research suggests.
    Medscape Medical News, February 24, 2009
  • Low-Income Countries Bear Biggest Burden of Stroke

    A new analysis of global surveillance data shows that rates of stroke mortality and burden vary between countries, but lower-income countries appear to be most affected.
    Medscape Medical News, February 24, 2009
  • "Counterintuitive" Treatment for IVH Improves Mortality, Functional Outcome

    Final data from the Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage show that treating this usually lethal condition with low-dose tissue plasminogen activator improves not only survival but also patients' functional independence at 6 months.
    Medscape Medical News, February 23, 2009
  • JUPITER Stroke Results Show Significant Reduction in Stroke Risk

    Stroke end-point results from the landmark JUPITER trial that showed benefit from rosuvastatin treatment in patients with normal cholesterol levels but elevated CRP show a 48% relative reduction for total stroke, with no increase in hemorrhagic stroke.
    Medscape Medical News, February 20, 2009
  • Misdiagnosis of Young Stroke Patients Not Uncommon

    It is not uncommon for young adults with stroke to be misdiagnosed during initial presentation to the emergency department, particularly if they experience an infarct in their posterior circulation.
    Medscape Medical News, February 19, 2009
  • Stroke Patients Arriving Within "Golden Hour" More Likely to Get tPA

    A greater proportion of stroke patients arriving within 1 hour of symptom onset -- the so-called "golden hour" -- receive thrombolytic therapy, although door-to-needle times were actually longer, suggesting doctors may be using the extra time to deliberate the decision to treat.
    Medscape Medical News, February 19, 2009
Disclaimer

The materials presented here do not reflect the views of Medscape, LLC, or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape, LLC, and do not represent a publication of the International Stroke Conference. These materials and the related activity are not sanctioned by the International Stroke Conference or any commercial supporters of the conference and do not constitute an official part of that conference.